Excalipoint Therapeutics and DP Technology Partnership | Lucid Diligence Brief
Excalipoint Therapeutics and DP Technology have partnered to develop an agentic…
Public Health Strategic Roundup | June 11–July 15, 2026
Key Strategic Developments Shaping Public Health Coverage: June 11–July 15,…
DermaSensor AI dermatology devices | Lucid Diligence Brief
AI dermatology devices are advancing beyond validation studies as DermaSensor…
Lucid Diligence Brief: Unio Health Partners and Thesis Care partnership
Lucid Diligence Brief: Unio Health Partners and Thesis Care’s AI clinical teams…
Lucid Diligence Brief: Insilico and Human Longevity collaboration
Lucid Diligence Brief: Insilico Medicine and Human Longevity collaborate on AI…
Lucid Diligence Brief: NeuroXT and BIDMC Expand Alzheimer’s AI Imaging Collaboration
Lucid Diligence Brief: NeuroXT and BIDMC expand their Alzheimer’s AI imaging…
AI in Healthcare and Digital Health Today—May 26, 2026
This week’s AI in Healthcare and Digital Health update highlights…
Lucid Diligence Brief: Plus Therapeutics and Ephemeral AI Partnership in CNS Oncology
Lucid Diligence Brief: Plus Therapeutics and Ephemeral AI partnership raises…
Lucid Diligence Brief: Helio Genomics and Syneos Health Deal
Lucid Diligence Brief: Helio Genomics and Syneos Health Deal to expand…
Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology Research Sites
Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology…
Lucid Diligence Brief: Roche to acquire PathAI
Lucid Diligence Brief: Roche acquires PathAI for USD 1.05B to advance AI…
Lucid Diligence Brief: Axoft $55 million Series A
Lucid Diligence Brief: Axoft $55 million Series A Professional audiences only.…